Effectiveness and safety of perampanel as early add-on treatment in patients with epilepsy and focal seizures in the routine clinical practice: Spain prospective study (PERADON)-Reference-Cited by-同舟云学术

Effectiveness and safety of perampanel as early add-on treatment in patients with epilepsy and focal seizures in the routine clinical practice: Spain prospective study (PERADON)

Published:2020-01 Issue: Volume:102 Page:106655
ISSN:1525-5050
Container-title:Epilepsy & Behavior
language:en
Short-container-title:Epilepsy & Behavior

Author:

Abril Jaramillo Javier,Estévez María José Carlos,Girón Úbeda Juan Miguel,Vega López Óscar,Calzado Rivas María Elena,Pérez Díaz Hernando,García Martín Guillermina,Vila Herrero Elena,Chamorro-Muñoz M.,Vázquez F.,De la Fuente C.,Redondo L.,Peláez N.,Santágueda Patricia,Rodríguez Uranga Juan Jesús

Funder

Eisai Spain

Esteve Pharmaceuticals

Publisher

Elsevier BV

Subject

Behavioral Neuroscience,Neurology (clinical),Neurology

Reference45 articles.

1. Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015;Group GBDNDC;Lancet Neurol,2017

2. Key facts;Epilepsy,2019

3. The epidemiology of drug-resistant epilepsy: a systematic review and meta-analysis;Kalilani;Epilepsia,2018

4. Drug regimens in patients with medication-resistant epilepsy in neurology and epilepsy outpatient departments in Spain;Rufo-Campos;Rev Neurol,2008

5. Interictal psychiatric comorbidities of drug-resistant focal epilepsy: prevalence and influence of the localization of the epilepsy.;Jansen;Epilepsy Behav.,2019

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perampanel in post-stroke epilepsy: Clinical practice data from the PERampanel as Only Concomitant antiseizure medication (PEROC) study;Journal of the Neurological Sciences;2024-07

2. Atypical course of severe myoclonic epilepsy of infancy (Dravet syndrome);Epilepsy and paroxysmal conditions;2024-06-30

3. Perampanel as monotherapy or first adjunctive therapy in pediatric and adult patients with epilepsy: the first United States-based phase IV open-label ELEVATE study;Journal of Neurology;2024-05-10

4. Phase IV PROVE study: Perampanel in real-world clinical care of pediatric patients with epilepsy;European Journal of Paediatric Neurology;2024-05

5. Long-term efficacy and safety of perampanel as an add-on therapy in patients with epilepsy;Epilepsy Research;2024-02